The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
IRVINE, Calif., Nov. 18, 2025 /PRNewswire/ -- Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic partnership with biomodal, an omics-based life sciences ...
Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...
Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based ...
Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...
In this interview, Dr. Anderson discusses the advantages of dd-cfDNA as a transplant monitoring tool and the regulatory and clinical hurdles that must be overcome before dd-cfDNA testing can be fully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback